Medicine guide
Jcovden (previously COVID-19 Vaccine Janssen)
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- COVID-19 vaccine (Ad26.COV2-S [recombinant])
- Made by
- Janssen-Cilag International NV
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Jcovden is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. The use of this vaccine should be in accordance with official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
Details
| Made by | Janssen-Cilag International NV |
|---|---|
| Active substance | COVID-19 vaccine (Ad26.COV2-S [recombinant]) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07BN02 · Antibiotics, antivirals and antifungals taken into the body |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2021-03-11 |
| Last updated by the regulator | 2025-09-01 |
| EMA product number | EMEA/H/C/005737 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).